Clinical trial
A Long Term Study of YM060 in Female Patients With Diarrhea-predominant Irritable Bowel Syndrome
NCT01736423 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Long Term Study of YM060 in Female Patients With Diarrhea-predominant Irritable Bowel Syndrome
- Lead sponsor
- Astellas Pharma Inc
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 30, 2012
- Completion date
- May 31, 2014
- Enrollment
- 151 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
diarrhea-predominant irritable bowel syndrome